Surfactant disaturated-phosphatidylcholine kinetics in acute respiratory distress syndrome by stable isotopes and a two compartment model

被引:15
作者
Cogo, Paola E. [1 ]
Toffolo, Gianna Maria
Ori, Carlo
Vianello, Andrea
Chierici, Marco
Gucciardi, Antonina
Cobelli, Claudio
Baritussio, Aldo
Carnielli, Virgilio P.
机构
[1] Univ Padua, Dept Pediat, I-35100 Padua, Italy
[2] Univ Padua, Dept Informat Engn, I-35100 Padua, Italy
[3] Univ Padua, Dept Pharmacol Aanesthesia & Crit Care, I-35100 Padua, Italy
[4] Gen Med Hosp, Resp Unit, Padua, Italy
[5] Univ Padua, Dept Med & Surg Sci, I-35100 Padua, Italy
[6] Salesi Childrens Hosp, Div Neonatol, Ancona, Italy
[7] Inst Child Hlth, Nutr Unit, London, England
[8] Great Ormond St Hosp Sick Children, London, England
关键词
D O I
10.1186/1465-9921-8-13
中图分类号
R56 [呼吸系及胸部疾病];
学科分类号
摘要
Background: In patients with acute respiratory distress syndrome (ARDS), it is well known that only part of the lungs is aerated and surfactant function is impaired, but the extent of lung damage and changes in surfactant turnover remain unclear. The objective of the study was to evaluate surfactant disaturated-phosphatidylcholine turnover in patients with ARDS using stable isotopes. Methods: We studied 12 patients with ARDS and 7 subjects with normal lungs. After the tracheal instillation of a trace dose of C-13-dipalmitoyl-phosphatidylcholine, we measured the C-13 enrichment over time of palmitate residues of disaturated-phosphatidylcholine isolated from tracheal aspirates. Data were interpreted using a model with two compartments, alveoli and lung tissue, and kinetic parameters were derived assuming that, in controls, alveolar macrophages may degrade between 5 and 50% of disaturated-phosphatidylcholine, the rest being lost from tissue. In ARDS we assumed that 5-100% of disaturated-phosphatidylcholine is degraded in the alveolar space, due to release of hydrolytic enzymes. Some of the kinetic parameters were uniquely determined, while others were identified as lower and upper bounds. Results: In ARDS, the alveolar pool of disaturated-phosphatidylcholine was significantly lower than in controls (0.16 +/- 0.04 vs. 1.31 +/- 0.40 mg/kg, p < 0.05). Fluxes between tissue and alveoli and de novo synthesis of disaturated-phosphatidylcholine were also significantly lower, while mean resident time in lung tissue was significantly higher in ARDS than in controls. Recycling was 16.2 +/- 3.5 in ARDS and 31.9 +/- 7.3 in controls (p = 0.08). Conclusion: In ARDS the alveolar pool of surfactant is reduced and disaturated-phosphatidylcholine turnover is altered.
引用
收藏
页数:12
相关论文
共 46 条
[1]  
[Anonymous], [No title captured]
[2]   Aerosolized surfactant in adults with sepsis-induced acute respiratory distress syndrome [J].
Anzueto, A ;
Baughman, RP ;
Guntupalli, KK ;
Weg, JG ;
Wiedemann, HP ;
Raventos, AA ;
Lemaire, F ;
Long, W ;
Zaccardelli, DS ;
Pattishall, EN .
NEW ENGLAND JOURNAL OF MEDICINE, 1996, 334 (22) :1417-1421
[3]   Induction of type-IIA secretory phospholipase A2 in animal models of acute lung injury [J].
Attalah, HL ;
Wu, Y ;
Alaoui-El-Azher, M ;
Thouron, F ;
Koumanov, K ;
Wolf, C ;
Brochard, L ;
Harf, A ;
Delclaux, C ;
Touqui, L .
EUROPEAN RESPIRATORY JOURNAL, 2003, 21 (06) :1040-1045
[4]   SURFACTANT PROTEIN-C IS RECYCLED FROM THE ALVEOLI TO THE LAMELLAR BODIES [J].
BARITUSSIO, A ;
PETTENAZZO, A ;
BENEVENTO, M ;
ALBERTI, A ;
GAMBA, P .
AMERICAN JOURNAL OF PHYSIOLOGY, 1992, 263 (05) :L607-L611
[5]   SAAM II: Simulation, Analysis, and Modeling Software for tracer and pharmacokinetic studies [J].
Barrett, PHR ;
Bell, BM ;
Cobelli, C ;
Golde, H ;
Schumitzky, A ;
Vicini, P ;
Foster, DM .
METABOLISM-CLINICAL AND EXPERIMENTAL, 1998, 47 (04) :484-492
[6]   Exogenous surfactant replacement in ARDS - One day, someday, or never? [J].
Baudouin, SV .
NEW ENGLAND JOURNAL OF MEDICINE, 2004, 351 (09) :853-855
[7]   THE AMERICAN-EUROPEAN CONSENSUS CONFERENCE ON ARDS - DEFINITIONS, MECHANISMS, RELEVANT OUTCOMES, AND CLINICAL-TRIAL COORDINATION [J].
BERNARD, GR ;
ARTIGAS, A ;
BRIGHAM, KL ;
CARLET, J ;
FALKE, K ;
HUDSON, L ;
LAMY, M ;
LEGALL, JR ;
MORRIS, A ;
SPRAGG, R ;
COCHIN, B ;
LANKEN, PN ;
LEEPER, KV ;
MARINI, J ;
MURRAY, JF ;
OPPENHEIMER, L ;
PESENTI, A ;
REID, L ;
RINALDO, J ;
VILLAR, J ;
VANASBECK, BS ;
DHAINAUT, JF ;
MANCEBO, J ;
MATTHAY, M ;
MEYRICK, B ;
PAYEN, D ;
PERRET, C ;
FOWLER, AA ;
SCHALLER, MD ;
HUDSON, LD ;
HYERS, T ;
KNAUS, W ;
MATTHAY, R ;
PINSKY, M ;
BONE, RC ;
BOSKEN, C ;
JOHANSON, WG ;
LEWANDOWSKI, K ;
REPINE, J ;
RODRIGUEZROISIN, R ;
ROUSSOS, C ;
ANTONELLI, MA ;
BELOUCIF, S ;
BIHARI, D ;
BURCHARDI, H ;
LEMAIRE, F ;
MONTRAVERS, P ;
PETTY, TL ;
ROBOTHAM, J ;
ZAPOL, W .
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 1994, 149 (03) :818-824
[8]  
BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911
[9]  
Christie WW., 1989, GAS CHROMATOGRAPHY L, P64
[10]  
Cobelli C, 2000, TRACER KINETICS BIOM